These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 35841977)
1. Identification of potential dilated cardiomyopathy-related targets by meta-analysis and co-expression analysis of human RNA-sequencing datasets. Yuan Z; Murakoshi N; Xu D; Tajiri K; Okabe Y; Aonuma K; Murakata Y; Li S; Song Z; Shimoda Y; Mori H; Aonuma K; Ieda M Life Sci; 2022 Oct; 306():120807. PubMed ID: 35841977 [TBL] [Abstract][Full Text] [Related]
2. Meta-Analysis of Dilated Cardiomyopathy Using Cardiac RNA-Seq Transcriptomic Datasets. Alimadadi A; Munroe PB; Joe B; Cheng X Genes (Basel); 2020 Jan; 11(1):. PubMed ID: 31948008 [TBL] [Abstract][Full Text] [Related]
3. Identification of Target Genes and Transcription Factors in Mice with LMNA-Related Dilated Cardiomyopathy by Integrated Bioinformatic Analyses. Zhou H; Tan L; Lu T; Xu K; Li C; Liu Z; Peng H; Shi R; Zhang G Med Sci Monit; 2020 Jun; 26():e924576. PubMed ID: 32581210 [TBL] [Abstract][Full Text] [Related]
4. Combining Bulk and Single Cell RNA-Sequencing Data to Identify Hub Genes of Fibroblasts in Dilated Cardiomyopathy. Huang X; Zhao X; Li Y; Feng Y; Zhang G; Wang Q; Xu C J Inflamm Res; 2024; 17():5375-5388. PubMed ID: 39161677 [TBL] [Abstract][Full Text] [Related]
5. Multiomics Analysis of Transcriptome, Epigenome, and Genome Uncovers Putative Mechanisms for Dilated Cardiomyopathy. Liu L; Huang J; Liu Y; Pan X; Li Z; Zhou L; Lai T; Chen C; Wei B; Mo J; Wei Q; Yan W; Huang X; Zhang Z; Zhang Z; Huang M; He F; Huang Z Biomed Res Int; 2021; 2021():6653802. PubMed ID: 33860048 [TBL] [Abstract][Full Text] [Related]
6. Exploration of dilated cardiomyopathy for biomarkers and immune microenvironment: evidence from RNA-seq. Fang C; Lv Z; Yu Z; Wang K; Xu C; Li Y; Wang Y BMC Cardiovasc Disord; 2022 Jul; 22(1):320. PubMed ID: 35850644 [TBL] [Abstract][Full Text] [Related]
7. Exploring the Communal Pathogenesis, Ferroptosis Mechanism, and Potential Therapeutic Targets of Dilated Cardiomyopathy and Hypertrophic Cardiomyopathy Wang Z; Xia Q; Su W; Cao M; Sun Y; Zhang M; Chen W; Jiang T Front Cardiovasc Med; 2022; 9():824756. PubMed ID: 35282347 [TBL] [Abstract][Full Text] [Related]
8. Integrated microarray analysis to identify potential biomarkers and therapeutic targets in dilated cardiomyopathy. Zhang H; Huo J; Jiang W; Shan Q Mol Med Rep; 2020 Aug; 22(2):915-925. PubMed ID: 32626989 [TBL] [Abstract][Full Text] [Related]
9. Downregulation of AC061961.2, LING01-AS1, and RP11-13E1.5 is associated with dilated cardiomyopathy progression. Qiu Z; Ye B; Yin L; Chen W; Xu Y; Chen X J Cell Physiol; 2019 Apr; 234(4):4460-4471. PubMed ID: 30203513 [TBL] [Abstract][Full Text] [Related]
10. Identification of Potential Biomarkers Associated with Dilated Cardiomyopathy by Weighted Gene Coexpression Network Analysis. Guo Q; Qu Q; Wang L; Liao S; Zhu X; Du A; Zhu Q; Cheang I; Gao R; Li X Front Biosci (Landmark Ed); 2022 Aug; 27(8):246. PubMed ID: 36042172 [TBL] [Abstract][Full Text] [Related]
11. Bioinformatics prediction of potential mechanisms and biomarkers underlying dilated cardiomyopathy. Liu Z; Song YN; Chen KY; Gao WL; Chen HJ; Liang GY World J Cardiol; 2022 May; 14(5):282-296. PubMed ID: 35702326 [TBL] [Abstract][Full Text] [Related]
12. Gene expression profiling reveals genes and transcription factors associated with dilated and ischemic cardiomyopathies. Qiao A; Zhao Z; Zhang H; Sun Z; Cui X Pathol Res Pract; 2017 May; 213(5):548-557. PubMed ID: 28318762 [TBL] [Abstract][Full Text] [Related]
13. Integrative bioinformatics analysis of potential therapeutic targets and immune infiltration characteristics in dilated cardiomyopathy. Yang Y; Liu P; Teng R; Liu F; Zhang C; Lu X; Ding Y Ann Transl Med; 2022 Mar; 10(6):348. PubMed ID: 35433958 [TBL] [Abstract][Full Text] [Related]
14. Identification of key immune-related genes in dilated cardiomyopathy using bioinformatics analysis. Li F; Du TY; Wu LD; Zhang L; Liu HH; Zhang ZY; Zhang J; Zhang ZY; Qian LL; Wang RX; Hao JF Sci Rep; 2023 Feb; 13(1):1820. PubMed ID: 36725968 [TBL] [Abstract][Full Text] [Related]
15. Transcriptome analysis of human heart failure reveals dysregulated cell adhesion in dilated cardiomyopathy and activated immune pathways in ischemic heart failure. Sweet ME; Cocciolo A; Slavov D; Jones KL; Sweet JR; Graw SL; Reece TB; Ambardekar AV; Bristow MR; Mestroni L; Taylor MRG BMC Genomics; 2018 Nov; 19(1):812. PubMed ID: 30419824 [TBL] [Abstract][Full Text] [Related]
16. Integrated bioinformatics analysis for identifying key genes and pathways in female and male patients with dilated cardiomyopathy. Zhang M; Wang X; Chen W; Liu W; Xin J; Yang D; Zhang Z; Zheng X Sci Rep; 2023 Jun; 13(1):8977. PubMed ID: 37268658 [TBL] [Abstract][Full Text] [Related]
17. Integrated analysis of single-cell RNA sequencing and bulk RNA data reveals gene regulatory networks and targets in dilated cardiomyopathy. Zhang M; Zhang X; Niu J; Hua C; Liu P; Zhong G Sci Rep; 2024 Jun; 14(1):13942. PubMed ID: 38886541 [TBL] [Abstract][Full Text] [Related]
18. Co-expression analysis provides important module and pathways of human dilated cardiomyopathy. Xiao J; Li F; Yang Q; Zeng XF; Ke ZP J Cell Physiol; 2020 Jan; 235(1):494-503. PubMed ID: 31236962 [TBL] [Abstract][Full Text] [Related]
20. Exploring the pathogenesis and immune infiltration in dilated cardiomyopathy complicated with atrial fibrillation by bioinformatics analysis. Gan T; Hu J; Aledan AKO; Liu W; Li C; Lu S; Wang Y; Xu Q; Wang Y; Wang Z Front Immunol; 2023; 14():1049351. PubMed ID: 36733486 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]